Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Research Reports > Portable Oxygen Concentrators Market to Register 7.8% CAGR Through 2026; Sales to Surge as Oxygen Therapy Becomes Crucial in Covid-19 Treatments

Research Reports

Portable Oxygen Concentrators Market to Register 7.8% CAGR Through 2026; Sales to Surge as Oxygen Therapy Becomes Crucial in Covid-19 Treatments

Published by linker 5

Posted on February 19, 2021

3 min read

Last updated: January 21, 2026

Bronchoscope with flexible design, essential for respiratory diagnostics - Global Banking & Finance Review — This image showcases a flexible bronchoscope, a crucial device for diagnosing respiratory conditions, aligning with the projected market growth to 2028. Its advanced functionality supports Covid-19 diagnostic applications.

Portable oxygen concentrator manufacturers are largely concerned with the maintenance of inventories throughout the coronavirus crisis, with optimization of supply chains and distribution channels.

The portable oxygen concentrators market is projected to reflect a highly promising 7.8% CAGR between the years of forecast from 2016 to 2026. The coronavirus outbreak is characterized by major respiratory symptoms owing to potentially low levels of oxygen in the patient’s body. Oxygen therapy is a crucial aspect of Covid-19 treatments, which is expected to strongly support the demand for portable oxygen concentrators throughout the crisis period.

“Portable oxygen concentrators are easy to carry and a number of variants are also approved for applications in airplanes. Coupled with the growing geriatric population and incidences of respiratory disease, the demand for portable oxygen concentrators is likely to continue growing in years to come,” states the FMI analyst.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1061

Portable Oxygen Concentrators Market- Critical Takeaways

Pulse flow technologies in portable oxygen concentrators are witnessing increasing demand owing to superior efficacy in treating COPD and other breathing problems.
Home setting applications are contributing significantly to revenue, supported by owing to the trend of miniaturization and easy application of oxygen therapies.
North America remains a leading market for portable oxygen concentrators owing to favorable government initiatives and a vast and widespread geriatric population.

Portable Oxygen Concentrators Market- Drivers

Rising incidences of respiratory ailments such as COPD around the world supports market growth.
Government spending on healthcare infrastructure and geriatric care provides lucrative opportunities.

Portable Oxygen Concentrators Market- Restraints

Strict regulations associated with approval and use of portable oxygen concentrators hinder market growth.
Prohibitory costs of portable oxygen concentrators, and lack of awareness in rural areas restrain adoption rates.

Coronavirus Impact on Portable Oxygen Concentrators Market

With the rapid spread of the coronavirus pandemic, the demand for essential medical equipment has shot up. The potentially severe respiratory symptoms, from poor oxygen levels in the patient’s bloodstream will bolster the demand for portable oxygen concentrators. Effective applications in home and hospital settings will contribute to adoption rates and revenue. Manufacturers will remain largely concerned with efforts to optimize supply and distribution channels to circumvent potential challenges from lockdown measures imposed in multiple countries.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-1061

Competitive Landscape

GCE Group, Koninklijke Philips N.V., O2 Concepts LLC, Inogen Inc., Foshan Keyhub Electronic Industries Co. Ltd., Chart Industries Inc., Oxus America Inc., Resmed Inc., Besco Medical Co., Invacare Corp., Precision Medical Inc., and Drive DeVilbiss Healthcare are some of the leading players in the portable oxygen concentrators market.

Manufacturers in the portable oxygen concentrators market are largely displaying interest in the development and launch of new products to boost functionality and widen their portfolios.

For instance, CAIRE Inc. has unveiled a next generation Freestyle Comfort portable oxygen concentrator with proprietary, self-adjusting functionality. OxygenToGo LLC has entered into a deal to provide Virgin Atlantic with portable oxygen concentrators for use in aircrafts. Similarly, ResMed has unveiled Mobi, a portable oxygen concentrator for COPD patients in the United States.